Methotrexate revisited: considerations for subcutaneous administration in RA
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methotrexate revisited: considerations for subcutaneous administration in RA
Authors
Keywords
Methotrexate, Polyglutamates, Rheumatoid arthritis, Subcutaneous
Journal
CLINICAL RHEUMATOLOGY
Volume 34, Issue 2, Pages 201-205
Publisher
Springer Nature
Online
2014-12-01
DOI
10.1007/s10067-014-2830-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration
- (2014) Michael H Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis
- (2014) Ediz Dalkilic et al. Modern Rheumatology
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Cost-minimisation analysis of subcutaneous methotrexate versus biologic therapy for the treatment of patients with rheumatoid arthritis who have had an insufficient response or intolerance to oral methotrexate
- (2013) Ray Fitzpatrick et al. CLINICAL RHEUMATOLOGY
- Rheumatoid arthritis and risk of acute myocardial infarction—A nationwide retrospective cohort study
- (2013) Wei-Sheng Chung et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Subcutaneous Methotrexate to Cut Costs?: Table 1.
- (2012) ROYA HASSANZADEH et al. JOURNAL OF RHEUMATOLOGY
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Effects of Changing from Oral to Subcutaneous Methotrexate on Red Blood Cell Methotrexate Polyglutamate Concentrations and Disease Activity in Patients with Rheumatoid Arthritis
- (2011) LISA K. STAMP et al. JOURNAL OF RHEUMATOLOGY
- Methotrexate: Optimizing the Efficacy in Rheumatoid Arthritis
- (2011) Jürgen Braun Therapeutic Advances in Musculoskeletal Disease
- Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke
- (2010) H. Kallberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study
- (2010) M. F. Bakker et al. ANNALS OF THE RHEUMATIC DISEASES
- An update on methotrexate
- (2010) Juergen Braun et al. CURRENT OPINION IN RHEUMATOLOGY
- What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases
- (2009) Jacqueline E Oliver et al. ARTHRITIS RESEARCH & THERAPY
- Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
- (2008) Sherine E. Gabriel AMERICAN JOURNAL OF MEDICINE
- Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
- (2008) K Visser et al. ANNALS OF THE RHEUMATIC DISEASES
- Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis
- (2008) Judith M. Dalrymple et al. ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now